Vicapsys Life Sciences, Inc. SEC filings VICP
Vicapsys Life Sciences, Inc. has 92 filings in SEC EDGAR's recent list, going back to Jul 17, 2009. Its latest annual report, Form 10-K, was filed on Oct 21, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Jan 10, 2025, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Dec 27, 2023 (material agreement, new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Aug 9, 2023 | Aug 9, 2023 |
| PRE 14C | Filing | Jul 28, 2023 | Jul 28, 2023 |
| DEF 14C | Information statement | Nov 21, 2022 | Nov 21, 2022 |
| DEF 14C | Information statement | May 17, 2022 | May 17, 2022 |
| PRE 14C | Filing | May 6, 2022 | May 6, 2022 |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VICP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Cumming, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1468639
- Former names
- SSGI, INC. (until Nov 7, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.